Echocardiographic evaluation of patients undergoing cancer therapy

Eur Heart J Cardiovasc Imaging. 2021 Mar 22;22(4):375-382. doi: 10.1093/ehjci/jeaa341.

Abstract

As advances in oncology therapies lead to significant improvement in life expectancy of many cancer entities, short-, and long-term cardiac side effects of oncology treatments gain increasing importance. In search of new screening modalities, echocardiography currently presents the best established and clinically easily feasible tool to detect cardiotoxicity in patients undergoing cancer therapy. This review focusses on the most commonly used oncology therapies and aims to give a practical approach to guide clinicians caring for this growing number of patients.

Keywords: cancer; cardio-oncology; chemotherapy; echocardiography; heart failure; strain.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Cardiotoxicity
  • Echocardiography
  • Heart Failure*
  • Humans
  • Neoplasms* / diagnostic imaging
  • Neoplasms* / drug therapy

Substances

  • Antineoplastic Agents